Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangzhan Sun

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cell Death & Disease|October 11, 2023
USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPCJingyi Zheng, Shasha Wu, Mao Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 8, 2024
ASH1L in Hepatoma Cells and Hepatic Stellate Cells Promotes Fibrosis-Associated Hepatocellular Carcinoma by Modulating Tumor-Associated MacrophagesYuyang Du, Shasha Wu, Shaoyan Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2025
ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNALiangzhan Sun, Pengchao Hu, Hui Yang, et al.
Oncogene|November 30, 2021
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitorLiangzhan Sun, Shaoyan Xi, Zhengdong Zhou, et al.
Cell Death and Differentiation|January 27, 2021
PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factorsQian Yan, Yu Zhang, Xiaona Fang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cell Death & Disease|October 11, 2023
USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPCJingyi Zheng, Shasha Wu, Mao Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 8, 2024
ASH1L in Hepatoma Cells and Hepatic Stellate Cells Promotes Fibrosis-Associated Hepatocellular Carcinoma by Modulating Tumor-Associated MacrophagesYuyang Du, Shasha Wu, Shaoyan Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2025
ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNALiangzhan Sun, Pengchao Hu, Hui Yang, et al.
Oncogene|November 30, 2021
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitorLiangzhan Sun, Shaoyan Xi, Zhengdong Zhou, et al.
Cell Death and Differentiation|January 27, 2021
PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factorsQian Yan, Yu Zhang, Xiaona Fang, et al.
Pageof 2